Flavius Nascimento
Gerontology · Coral Springs, FLNPI 1730625757
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $160,288 of the $225,719 with a category attached, or 71.0%. Fresenius USA Marketing, Inc. accounts for 94.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $95,551 and has fallen 81.6% since, to $17,550 in 2025. Among gerontology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 400 payments — averaging $564.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$213K
- Akebia Therapeutics Inc$12K
- AstraZeneca$145
- Vifor Pharma, Inc.$125
- Travere Therapeutics, Inc.$99
- Amgen$70
- plus $219 from 6 others
What the payments were for
- Consulting fees$12,7506%
- Speaking & faculty fees$160,28871%
- Travel & lodging$45,25720%
- Food & beverage$7,4243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius USA Marketing, Inc. | 328 | $212,687 |
| Akebia Therapeutics Inc | 51 | $12,373 |
| AstraZeneca | 2 | $145 |
| Vifor Pharma, Inc. | 2 | $125 |
| Travere Therapeutics, Inc. | 4 | $99 |
| Amgen | 4 | $70 |
| Bayer | 3 | $65 |
| Ardelyx, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Novo Nordisk | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$225,719 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 119 | $275,452 |
| AuryxiaFerric Citrate | 25 | $53,719 |
| EliquisApixaban | 14 | $20,638 |
| ProsolParenteral Amino Acid 20% No.1 | 31 | $7,260 |
| Sevelamer Carbonate | 49 | $6,806 |
| Calcium Acetate | 16 | $2,343 |
| Nifedipine ErNifedipine | 19 | $603 |
| Midodrine Hcl | 15 | $438 |
| Gabapentin | 16 | $242 |
| Hydralazine Hcl | 16 | $220 |
| Losartan Potassium | 30 | $205 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $170 |
| Tamsulosin Hcl | 13 | $139 |
| Mupirocin | 14 | $136 |
| Lisinopril | 17 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $212,687 | $275,452119 claims |
| Akebia Therapeutics IncAuryxia | $12,373 | $53,71925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 gerontology providers in Florida.
Other gerontology in Coral Springs
- Michelle HartogWinter Park$90K
- Alejandra Rosales-CohenOrange City$88K
- Jennifer PacilettiAtlantis$66K
- Tatiana ClarkBradenton$34K
- Brandi LigonWinter Park$27K
- Boni MayOrlando$22K
- Dennis VerducciMiami$22K
- Christina Duffy-HenriquesMaitland$19K
- Nichole StanleyNaples$18K
- Jill HunterBradenton$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.